文献速递肾小球疾病急性肾损伤

抗GBM肾小球肾炎的结局预测

Predicting Outcome in Patients with Anti-GBM Glomerulonephritis.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-11-21

该回顾性多中心研究纳入1986至2015年间123例抗GBM肾小球肾炎患者,按ANCA相关GN病理分类标准分类肾活检,分析预测终末期肾病(ESRD)的临床和病理参数。5年肾脏生存率为34%,2007年后诊断者生存率改善(P=0.01)。多变量分析显示就诊时依赖透析、正常肾小球比例低和间质浸润范围大是ESRD的预测因素。

要点

  • 抗GBM GN患者5年肾脏生存率34%,2007年后诊断者生存率改善(P=0.01)。
  • 局灶型(≥50%正常肾小球)患者15例中仅1例进展至ESRD。
  • 硬化型(≥50%全球硬化肾小球)或100%细胞性新月体患者未脱离透析依赖。

核心结论

  • 就诊时依赖透析、正常肾小球比例低和间质浸润范围大与抗GBM GN肾脏不良结局相关。
  • 近年来肾脏结局改善,2007年后成功率翻倍。

研究设计与样本

  • 回顾性分析纳入1986至2015年间来自全球六中心的123例抗GBM GN患者。
  • 肾活检样本按ANCA相关GN组织病理学分类标准分类,临床数据从病历中提取。
  • 主要结局参数为ESRD发生,肾脏生存采用log-rank检验和Cox回归分析。

主要发现

  • 5年肾脏生存率为34%,2007年后诊断患者生存率改善(P=0.01)。
  • 组织病理学分类与肾脏生存相关(P<0.001)。
  • 局灶型(≥50%正常肾小球)15例中仅1例发生ESRD。
  • 硬化型(≥50%全球硬化肾小球)和100%细胞性新月体患者就诊时透析依赖未恢复。
  • 多变量分析中,就诊时透析依赖(HR 3.17;95%CI 1.59-6.32)、正常肾小球百分比(HR 0.97;95%CI 0.95-0.99)和间质浸润范围(HR 2.02;95%CI 1.17-3.50)是随访期间ESRD的预测因素。

临床怎么用

  • 对就诊时依赖透析、正常肾小球比例低或间质浸润范围大的抗GBM GN患者应加强监测和干预。
  • 肾活检病理分类有助于预测肾脏结局,可指导临床决策。

局限性

  • 回顾性分析设计可能引入偏倚。
  • 样本来自六个中心,可能存在选择偏倚。
  • 研究时间跨度为1986至2015年,治疗实践可能随时间变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Large studies on long-term kidney outcome in patients with anti-glomerular basement membrane (anti-GBM) GN are lacking. This study aimed to identify clinical and histopathologic parameters that predict kidney outcome in these patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective analysis included a total of 123 patients with anti-GBM GN between 1986 and 2015 from six centers worldwide. Their kidney biopsy samples were classified according to the histopathologic classification for ANCA-associated GN. Clinical data such as details of treatment were retrieved from clinical records. The primary outcome parameter was the occurrence of ESRD. Kidney survival was analyzed using the log-rank test and Cox regression analyses. RESULTS: The 5-year kidney survival rate was 34%, with an improved rate observed among patients diagnosed after 2007 (P=0.01). In patients with anti-GBM GN, histopathologic class and kidney survival were associated (P<0.001). Only one of 15 patients with a focal class biopsy sample (≥50% normal glomeruli) developed ESRD. Patients with a sclerotic class biopsy sample (≥50% globally sclerotic glomeruli) and patients with 100% cellular crescents did not recover from dialysis dependency at presentation. In multivariable analysis, dialysis dependency at presentation (hazard ratio [HR], 3.17; 95% confidence interval [95% CI], 1.59 to 6.32), percentage of normal glomeruli (HR, 0.97; 95% CI, 0.95 to 0.99), and extent of interstitial infiltrate (HR, 2.02; 95% CI, 1.17 to 3.50) were predictors of ESRD during follow-up. CONCLUSIONS: Dialysis dependency, low percentage of normal glomeruli, and large extent of interstitial infiltrate are associated with poor kidney outcome in anti-GBM GN. Kidney outcome has improved during recent years; the success rate doubled after 2007. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2017_11_21_CJASNPodcast_18_1_v.mp3.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. van Daalen EE, Jennette JC, McAdoo SP, et al. Predicting Outcome in Patients with Anti-GBM Glomerulonephritis. Clin J Am Soc Nephrol. 2017. PMID: 29162595. doi:10.2215/CJN.04290417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。